Alexander Wang, MD
- Director, Continuity Clinic, UH Cleveland Medical Center
- Specialty: Neurology-Movement Disorders, Neurology
-
Location:UH Cleveland Medical Center Bolwell
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-3192
Biography: Alexander Wang, MD
Expertise
Certifications & Memberships
- Neurology - American Board of Psychiatry and Neurology
Education
Fellowship | Movement Disorders
Movement Disorders - UH Cleveland Medical Center (2020 - 2022)
Residency | Neurology
Neurology - UH Cleveland Medical Center (2016 - 2020)
Medical Education
University Of Toledo College Of Medicine (2016)
Undergraduate
University Of California Berkeley (2012)
About
View Dr. Wang’s Health TalksAlexander Wang, MD, is a neurologist in the Parkinson’s and Movement Disorders Center with the Neurological Institute and Assistant Professor of Neurology at Case Western Reserve University School of Medicine. Dr. Wang completed a B.A. in molecular and cell biology at the University of California, Berkeley. He completed medical school at University of Toledo College of Medicine. He came to Cleveland in 2016, where he completed an internship, neurology residency and movement disorders fellowship at University Hospitals Cleveland Medical Center. He joined as faculty in neurology in 2022. He sees patients at UH Medina and main campus.
Dr. Wang specializes in the treatment of movement disorders, including Parkinson’s disease, tremor and dystonia. Additionally, he performs botulinum toxin injections, as well as programming of deep brain stimulators. He participates in resident and fellowship education through clinical rotations, resident continuity clinic and didactics.Dr. Wang has published several articles pertaining to movement disorders in peer-reviewed journals. He is involved in ongoing research projects pertaining to dystonia and Parkinson’s disease, and he is in the process of co-authoring textbook chapters. He is a member of the American Academy of Neurology (AAN) and Movement Disorders Society (MDS).
Research & Publications
Research Interests
Movement disorders, Parkinson’s disease, Dystonia, Tremor, Deep Brain Stimulation
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Alexander Wang did not disclose any Outside Relationships with Industry.